APOA2 Antikörper (AA 1-101)

Produktnummer ABIN614396

Der Maus Monoklonal Anti-APOA2-Antikörper wurde für WB, IHC (p) und EIA validiert. Er ist geeignet, APOA2 in Proben von Human zu detektieren.

Kurzübersicht für APOA2 Antikörper (AA 1-101) (ABIN614396)

Target: APOA2 (Apolipoprotein A-II (APOA2))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser APOA2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Klon: 1H6

Produktdetails anti-APOA2 Antikörper

Bindungsspezifität: AA 1-101

Spezifität: Recognizes Apolipoprotein AII (APOA2).

Kreuzreaktivität (Details): Species reactivity (tested):Human.

Aufreinigung: Protein A Chromatography

Immunogen: APOA2 (AAH05282, 1 a.a. ~ 101 a.a) full-length recombinant protein with GST tag.

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS, pH 7.2

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store the antibody (in aliquots) at -20 °C.

Details zu APOA2

Target: APOA2 (Apolipoprotein A-II (APOA2))

Andere Bezeichnung: Apolipoprotein A II (Apo AII)

Hintergrund: Apolipoprotein A II is the second most abundant protein of the high density lipoprotein particles. The apolipoprotein A II gene consists of 4 exons and 3 introns. The four exons encode the 5' untranslated region, pre peptide, a short N terminal domain and a C terminal domain composed of a variable number of lipid binding amphipathic helices. Familial apolipoprotein A II deficiency may result from a splice junction alteration which blocks splicing of intron 3 from the primary transcript and result in the formation of a non functional mRNA.Synonyms: APOA2, Apo-AII, ApoA-II, Apolipoprotein A-II, Apolipoprotein A2

Gen-ID: 336

NCBI Accession: NP_001634

UniProt: P02652

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism